EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Policy options for the drug pricing conundrum

Kate Ho, Ariel Pakes

Proceedings of the National Academy of Sciences · 2025

DOI: 10.1073/pnas.2418540122 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2025. Verfasst von Kate Ho und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Economics, Princeton University and National Bureau for Economic Research, Princeton, NJ 08540. Hauptthemen laut MEDLINE: Drug Costs, Drug Industry. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Current proposals aimed at reducing U.S. pharmaceutical prices would have immediate benefits (particularly for low-income and elderly populations), but could dramatically reduce firms’ investment in potentially highly welfare-improving Research and Development (R&D). The United States subsidizes the worldwide pharmaceutical market: U.S. drug prices are more than 250% of those in other Organization for Economic Co-operation and Development (OECD) countries. If each drug had a single international price across the highest-income OECD countries and total pharmaceutical firm profits were held fixed: U.S. prices would fall by half; every other country’s prices would increase (by 28 to over 300%); and R&D incentives would be maintained. We propose a potential lever for the U.S. government to influence worldwide drug pricing: access to the Medicare market.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug CostsDrug IndustryUnited StatesHumansOrganisation for Economic Co-Operation and Development

Stichwörter der Autor:innen

pharmaceutical pricespoliciesworldwide drug pricing

Autor:innen und Institutionen

  • Department of Economics, Princeton University and National Bureau for Economic Research, Princeton, NJ 08540.
  • Department of Economics, Harvard University and NBER, Cambridge, MA 02138.

Zitieren

APA

Ho, K., & Pakes, A. (2025). Policy options for the drug pricing conundrum. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2418540122

Vancouver

Ho K, Pakes A. Policy options for the drug pricing conundrum. Proceedings of the National Academy of Sciences. 2025. doi:10.1073/pnas.2418540122

BibTeX
@article{Ho2025,
  author = {Ho, Kate and Pakes, Ariel},
  title = {Policy options for the drug pricing conundrum},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2025},
  doi = {10.1073/pnas.2418540122}
}
Kostenlos starten →